Ledger.Open graph →
SEC Form D · Amendment · filed September 26, 2013

Tyrosine Pharma Inc

Offering
$250K
Sold
$100K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Albuquerque, NM
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Alan Kolod · Albuquerque, NMExec · DirectorWayne Laslie · Albuquerque, NMExec · DirectorJohn Chavez · Albuquerque, NMDirectorSteve T. Rhodes · M.P. Misgav, L3Exec · DirectorRobert T. Kittel · Toronto, Ontario, CanadaExec · DirectorJohn Chavez · ALBUQUERQUE, NMDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗